| - GRCh37:
- Chr15:40763928
- GRCh38:
- Chr15:40471729
| CHST14 | | Ehlers-Danlos syndrome, musculocontractural type | Likely benign (May 21, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40764063
- GRCh38:
- Chr15:40471864
| CHST14 | | Ehlers-Danlos syndrome, musculocontractural type | Likely benign (Oct 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40764360
- GRCh38:
- Chr15:40472161
| CHST14 | | Ehlers-Danlos syndrome, musculocontractural type | Likely benign (Dec 13, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40763794
- GRCh38:
- Chr15:40471595
| CHST14 | D128H | Ehlers-Danlos syndrome, musculocontractural type | Uncertain significance (Feb 20, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40763948
- GRCh38:
- Chr15:40471749
| CHST14 | R179H | Ehlers-Danlos syndrome, musculocontractural type | Uncertain significance (Feb 28, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40764411
- GRCh38:
- Chr15:40472212
| CHST14 | | Ehlers-Danlos syndrome, musculocontractural type | Likely benign (Mar 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40763711
- GRCh38:
- Chr15:40471512
| CHST14 | A100V | Ehlers-Danlos syndrome, musculocontractural type | Uncertain significance (Jun 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40763925
- GRCh38:
- Chr15:40471726
| CHST14 | | Ehlers-Danlos syndrome, musculocontractural type | Likely benign (Jun 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40763640
- GRCh38:
- Chr15:40471441
| CHST14 | | Ehlers-Danlos syndrome, musculocontractural type, Cardiovascular phenotype | Likely benign (May 13, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:40764041
- GRCh38:
- Chr15:40471842
| CHST14 | L210P | Ehlers-Danlos syndrome, musculocontractural type | Uncertain significance (Feb 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40764450
- GRCh38:
- Chr15:40472251
| CHST14 | | Ehlers-Danlos syndrome, musculocontractural type | Likely benign (Oct 31, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40764428
- GRCh38:
- Chr15:40472229
| CHST14 | H339R | Ehlers-Danlos syndrome, musculocontractural type | Uncertain significance (Jan 16, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40763567
- GRCh38:
- Chr15:40471368
| CHST14 | A52V | Ehlers-Danlos syndrome, musculocontractural type | Uncertain significance (Mar 18, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40763414
- GRCh38:
- Chr15:40471215
| CHST14 | M1T | Ehlers-Danlos syndrome, musculocontractural type | Uncertain significance (Nov 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40764088-40764094
- GRCh38:
- Chr15:40471889-40471895
| CHST14 | K226fs | Ehlers-Danlos syndrome, musculocontractural type | Pathogenic (Jul 16, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40763614
- GRCh38:
- Chr15:40471415
| CHST14 | M68V | Ehlers-Danlos syndrome, musculocontractural type | Uncertain significance (May 7, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40763523
- GRCh38:
- Chr15:40471324
| CHST14 | | Ehlers-Danlos syndrome, musculocontractural type | Likely benign (Mar 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40764347
- GRCh38:
- Chr15:40472148
| CHST14 | W312L | Ehlers-Danlos syndrome, musculocontractural type | Uncertain significance (Jul 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40763477
- GRCh38:
- Chr15:40471278
| CHST14 | L22P | Ehlers-Danlos syndrome, musculocontractural type | Uncertain significance (Oct 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40763547
- GRCh38:
- Chr15:40471348
| CHST14 | | Ehlers-Danlos syndrome, musculocontractural type | Likely benign (Sep 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40764416
- GRCh38:
- Chr15:40472217
| CHST14 | S335I | Ehlers-Danlos syndrome, musculocontractural type | Uncertain significance (Jul 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40763672
- GRCh38:
- Chr15:40471473
| CHST14 | K89fs | Ehlers-Danlos syndrome, musculocontractural type | Pathogenic (May 31, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40763898
- GRCh38:
- Chr15:40471699
| CHST14 | W162* | Ehlers-Danlos syndrome, musculocontractural type | Pathogenic (Jul 29, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40764105
- GRCh38:
- Chr15:40471906
| CHST14 | | Ehlers-Danlos syndrome, musculocontractural type | Uncertain significance (Aug 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40763516
- GRCh38:
- Chr15:40471317
| CHST14 | G35A | Ehlers-Danlos syndrome, musculocontractural type, Cardiovascular phenotype | Uncertain significance (Jun 24, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:40763460
- GRCh38:
- Chr15:40471261
| CHST14 | | Cardiovascular phenotype, Ehlers-Danlos syndrome, musculocontractural type | Likely benign (Jun 14, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:40763839
- GRCh38:
- Chr15:40471640
| CHST14 | V143I | Ehlers-Danlos syndrome, musculocontractural type, Cardiovascular phenotype | Uncertain significance (May 30, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:40763529
- GRCh38:
- Chr15:40471330
| CHST14 | | Ehlers-Danlos syndrome, musculocontractural type | Likely benign (Jan 27, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40763992
- GRCh38:
- Chr15:40471793
| CHST14 | | Ehlers-Danlos syndrome, musculocontractural type | Likely benign (Sep 14, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40763592
- GRCh38:
- Chr15:40471393
| CHST14 | | Ehlers-Danlos syndrome, musculocontractural type | Likely benign (Oct 7, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40764405
- GRCh38:
- Chr15:40472206
| CHST14 | | Cardiovascular phenotype, Ehlers-Danlos syndrome, musculocontractural type | Benign/Likely benign (Aug 6, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:40763667
- GRCh38:
- Chr15:40471468
| CHST14 | | Cardiovascular phenotype, Ehlers-Danlos syndrome, musculocontractural type | Likely benign (Jul 27, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:40763526
- GRCh38:
- Chr15:40471327
| CHST14 | | Ehlers-Danlos syndrome, musculocontractural type | Likely benign (Sep 23, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40763715
- GRCh38:
- Chr15:40471516
| CHST14 | | Ehlers-Danlos syndrome, musculocontractural type | Likely benign (Sep 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40764498
- GRCh38:
- Chr15:40472299
| CHST14 | | Ehlers-Danlos syndrome, musculocontractural type | Likely benign (Feb 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40763821
- GRCh38:
- Chr15:40471622
| CHST14 | | Ehlers-Danlos syndrome, musculocontractural type | Likely benign (Nov 20, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40763523
- GRCh38:
- Chr15:40471324
| CHST14 | | Cardiovascular phenotype, Ehlers-Danlos syndrome, musculocontractural type | Likely benign (Feb 14, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:40763511
- GRCh38:
- Chr15:40471312
| CHST14 | | Ehlers-Danlos syndrome, musculocontractural type | Likely benign (Oct 20, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40763913
- GRCh38:
- Chr15:40471714
| CHST14 | K167N | Ehlers-Danlos syndrome, musculocontractural type | Uncertain significance (Aug 28, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40763813
- GRCh38:
- Chr15:40471614
| CHST14 | R134Q | Ehlers-Danlos syndrome, musculocontractural type | Uncertain significance (Aug 31, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40763563
- GRCh38:
- Chr15:40471364
| CHST14 | V51M | Ehlers-Danlos syndrome, musculocontractural type | Uncertain significance (Aug 27, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40764144
- GRCh38:
- Chr15:40471945
| CHST14 | | Ehlers-Danlos syndrome, musculocontractural type, Cardiovascular phenotype | Likely benign (Mar 7, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:40763879
- GRCh38:
- Chr15:40471680
| CHST14 | K156R | Ehlers-Danlos syndrome, musculocontractural type | Uncertain significance (Aug 27, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40763657
- GRCh38:
- Chr15:40471458
| CHST14 | A82G | Ehlers-Danlos syndrome, musculocontractural type | Uncertain significance (Aug 14, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40764529
- GRCh38:
- Chr15:40472330
| CHST14 | A373S | Ehlers-Danlos syndrome, musculocontractural type | Uncertain significance (Sep 17, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40764283
- GRCh38:
- Chr15:40472084
| CHST14 | V291M | Ehlers-Danlos syndrome, musculocontractural type | Uncertain significance (Aug 26, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40764273
- GRCh38:
- Chr15:40472074
| CHST14 | | Cardiovascular phenotype, Ehlers-Danlos syndrome, musculocontractural type | Likely benign (Sep 26, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:40764175
- GRCh38:
- Chr15:40471976
| CHST14 | G255R | Ehlers-Danlos syndrome, musculocontractural type | Uncertain significance (Aug 27, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40763432
- GRCh38:
- Chr15:40471233
| CHST14 | T7N | Ehlers-Danlos syndrome, musculocontractural type, Ehlers-Danlos syndrome, musculocontractural type 1 | Uncertain significance (Oct 4, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:40763705
- GRCh38:
- Chr15:40471506
| CHST14 | G98E | Cardiovascular phenotype, Ehlers-Danlos syndrome, musculocontractural type | Uncertain significance (Aug 14, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:40764334
- GRCh38:
- Chr15:40472135
| CHST14 | Q308K | Ehlers-Danlos syndrome, musculocontractural type, Cardiovascular phenotype | Uncertain significance (Apr 5, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:40764345
- GRCh38:
- Chr15:40472146
| CHST14 | E311D | Ehlers-Danlos syndrome, musculocontractural type, Ehlers-Danlos syndrome, musculocontractural type 1, Cardiovascular phenotype
| Uncertain significance (Dec 11, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:40764054
- GRCh38:
- Chr15:40471855
| CHST14 | E214D | Ehlers-Danlos syndrome, musculocontractural type | Uncertain significance (Jul 20, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40763403-40764553
| CHST14 | | Ehlers-Danlos syndrome, musculocontractural type | Uncertain significance (Aug 27, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40763737
- GRCh38:
- Chr15:40471538
| CHST14 | R109W | Ehlers-Danlos syndrome, musculocontractural type, Cardiovascular phenotype | Uncertain significance (Aug 24, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:40764389
- GRCh38:
- Chr15:40472190
| CHST14 | A326V | Ehlers-Danlos syndrome, musculocontractural type | Uncertain significance (Jul 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40764331
- GRCh38:
- Chr15:40472132
| CHST14 | N307D | Cardiovascular phenotype, Ehlers-Danlos syndrome, musculocontractural type | Uncertain significance (Aug 7, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:40764116
- GRCh38:
- Chr15:40471917
| CHST14 | Q235R | Ehlers-Danlos syndrome, musculocontractural type | Uncertain significance (Aug 30, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40763860
- GRCh38:
- Chr15:40471661
| CHST14 | L150V | Ehlers-Danlos syndrome, musculocontractural type | Uncertain significance (Aug 31, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40763413-40764543
| CHST14 | | Ehlers-Danlos syndrome, musculocontractural type | Uncertain significance (May 28, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40764104
- GRCh38:
- Chr15:40471905
| CHST14 | R231Q | Ehlers-Danlos syndrome, Ehlers-Danlos syndrome, musculocontractural type | Uncertain significance (Oct 4, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:40763790
- GRCh38:
- Chr15:40471591
| CHST14 | | Ehlers-Danlos syndrome, musculocontractural type | Likely benign (Sep 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40764098
- GRCh38:
- Chr15:40471899
| CHST14 | E229G | Ehlers-Danlos syndrome, musculocontractural type, Cardiovascular phenotype | Uncertain significance (Jul 25, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:40763455
- GRCh38:
- Chr15:40471256
| CHST14 | A15P | Cardiovascular phenotype, Ehlers-Danlos syndrome, musculocontractural type | Uncertain significance (Aug 31, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:40763420
- GRCh38:
- Chr15:40471221
| CHST14 | P3L | Ehlers-Danlos syndrome, musculocontractural type, Cardiovascular phenotype | Uncertain significance (Jun 27, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:40763948
- GRCh38:
- Chr15:40471749
| CHST14 | R179P | Ehlers-Danlos syndrome, musculocontractural type | Uncertain significance (Jun 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40763565-40763575
- GRCh38:
- Chr15:40471366-40471376
| CHST14 | S53fs | not provided, Ehlers-Danlos syndrome, musculocontractural type | Pathogenic/Likely pathogenic (Jul 19, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:40763622
- GRCh38:
- Chr15:40471423
| CHST14 | | Cardiovascular phenotype, Ehlers-Danlos syndrome, musculocontractural type | Benign/Likely benign (Feb 5, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:40764390
- GRCh38:
- Chr15:40472191
| CHST14 | | Cardiovascular phenotype, Ehlers-Danlos syndrome, musculocontractural type | Likely benign (Jan 15, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:40764396
- GRCh38:
- Chr15:40472197
| CHST14 | | Ehlers-Danlos syndrome, musculocontractural type | Likely benign (Dec 11, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40764234
- GRCh38:
- Chr15:40472035
| CHST14 | | Ehlers-Danlos syndrome, musculocontractural type | Likely benign (May 31, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40763601
- GRCh38:
- Chr15:40471402
| CHST14 | | Ehlers-Danlos syndrome, musculocontractural type, Cardiovascular phenotype | Likely benign (Jun 4, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:40763457
- GRCh38:
- Chr15:40471258
| CHST14 | | Ehlers-Danlos syndrome, musculocontractural type | Likely benign (Feb 5, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40763470
- GRCh38:
- Chr15:40471271
| CHST14 | R20W | Cardiovascular phenotype, not provided, Ehlers-Danlos syndrome, musculocontractural type
| Likely benign (Oct 21, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:40763874
- GRCh38:
- Chr15:40471675
| CHST14 | | Ehlers-Danlos syndrome, musculocontractural type | Likely benign (Mar 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40764213
- GRCh38:
- Chr15:40472014
| CHST14 | | Ehlers-Danlos syndrome, musculocontractural type | Likely benign (Jul 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40764021
- GRCh38:
- Chr15:40471822
| CHST14 | | Ehlers-Danlos syndrome, musculocontractural type | Likely benign (Aug 15, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40764255
- GRCh38:
- Chr15:40472056
| CHST14 | | Cardiovascular phenotype, Ehlers-Danlos syndrome, musculocontractural type | Likely benign (Aug 9, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:40763709
- GRCh38:
- Chr15:40471510
| CHST14 | | Ehlers-Danlos syndrome, musculocontractural type | Likely benign (Jul 29, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40764513
- GRCh38:
- Chr15:40472314
| CHST14 | | Ehlers-Danlos syndrome, musculocontractural type | Likely benign (Aug 31, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40764054
- GRCh38:
- Chr15:40471855
| CHST14 | | Ehlers-Danlos syndrome, musculocontractural type | Likely benign (Jul 3, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40763583
- GRCh38:
- Chr15:40471384
| CHST14 | L58fs | Ehlers-Danlos syndrome, musculocontractural type | Pathogenic (Aug 28, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40763695
- GRCh38:
- Chr15:40471496
| CHST14 | L95F | Ehlers-Danlos syndrome, musculocontractural type | Uncertain significance (Aug 24, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40764024
- GRCh38:
- Chr15:40471825
| CHST14 | Q204H | Ehlers-Danlos syndrome, musculocontractural type | Uncertain significance (Sep 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40763444
- GRCh38:
- Chr15:40471245
| CHST14 | A11V | Ehlers-Danlos syndrome, musculocontractural type | Uncertain significance (Aug 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40763707
- GRCh38:
- Chr15:40471508
| CHST14 | D99N | Ehlers-Danlos syndrome, musculocontractural type, Ehlers-Danlos syndrome, musculocontractural type 1 | Uncertain significance (Aug 24, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:40764004
- GRCh38:
- Chr15:40471805
| CHST14 | E198K | Ehlers-Danlos syndrome, musculocontractural type | Uncertain significance (Feb 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40763585
- GRCh38:
- Chr15:40471386
| CHST14 | L58P | Ehlers-Danlos syndrome, musculocontractural type | Uncertain significance (Sep 15, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40764099
- GRCh38:
- Chr15:40471900
| CHST14 | E229D | Ehlers-Danlos syndrome, musculocontractural type | Uncertain significance (Sep 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40763423
- GRCh38:
- Chr15:40471224
| CHST14 | R4P | Ehlers-Danlos syndrome, musculocontractural type | Uncertain significance (May 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40763870
- GRCh38:
- Chr15:40471671
| CHST14 | Y153C | Ehlers-Danlos syndrome, musculocontractural type | Uncertain significance (Jan 1, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40763550
- GRCh38:
- Chr15:40471351
| CHST14 | M46I | Ehlers-Danlos syndrome, musculocontractural type | Uncertain significance (Sep 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40764422
- GRCh38:
- Chr15:40472223
| CHST14 | H337R | Ehlers-Danlos syndrome, musculocontractural type | Uncertain significance (Oct 8, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40763608
- GRCh38:
- Chr15:40471409
| CHST14 | A66T | Ehlers-Danlos syndrome, musculocontractural type | Uncertain significance (Aug 28, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40764080
- GRCh38:
- Chr15:40471881
| CHST14 | Y223F | Ehlers-Danlos syndrome, musculocontractural type | Uncertain significance (Aug 26, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40763919-40763920
- GRCh38:
- Chr15:40471720-40471721
| CHST14 | A170S | Cardiovascular phenotype, not provided, Ehlers-Danlos syndrome, musculocontractural type
| Uncertain significance (Nov 15, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:40764097
- GRCh38:
- Chr15:40471898
| CHST14 | E229K | Ehlers-Danlos syndrome, musculocontractural type | Uncertain significance (Sep 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40764040
- GRCh38:
- Chr15:40471841
| CHST14 | L210V | Ehlers-Danlos syndrome, musculocontractural type | Uncertain significance (Sep 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40764141
- GRCh38:
- Chr15:40471942
| CHST14 | R243S | Ehlers-Danlos syndrome, musculocontractural type | Uncertain significance (Aug 28, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr15:40764155
- GRCh38:
- Chr15:40471956
| CHST14 | G248A | Inborn genetic diseases, Ehlers-Danlos syndrome, musculocontractural type, not provided
| Uncertain significance (Jul 12, 2023) | criteria provided, multiple submitters, no conflicts |